Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARL | Q9H300 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL379296 | 1.00 | PARL (0.34) | PARLALDH1A1PKMKMT2AATM | |
| SCHEMBL9513159 | 0.80 | — | — | |
| SCHEMBL1140513 | 0.78 | ALDH1A1 (0.33) | PARLALDH1A1PKMKMT2AATM | |
| SCHEMBL9150133 | 0.78 | ALDH1A1 (0.33) | PARLALDH1A1PKMKMT2AATM | |
| SCHEMBL28511792 | 0.74 | SMN1; SMN2 (0.37) | PARLALDH1A1PKMKMT2AATM | |
| SCHEMBL11989420 | 0.70 | PARL (0.31) | PARLKMT2AATM | |
| SCHEMBL13900968 | 0.70 | PARL (0.31) | PARLKMT2AATM | |
| SCHEMBL18914913 | 0.70 | GLA (0.33) | ALDH1A1KMT2AATM | |
| SCHEMBL57128 | 0.69 | PARL (0.38) | PARLKMT2AATMCA12CA1 | |
| SCHEMBL9976427 | 0.69 | PARL (0.33) | PARL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 518 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2971064-B1 | PROXIMITY ASSAY FOR IN SITU DETECTION OF TARGETS | VENTANA MED SYST INC (US) | 2019-10-16 | — | — | EP | claimed |
| EP-2282758-B1 | ANTIBODIES AND VACCINES FOR USE IN THERAPEUTIC AND DIAGNOSTIC METHODS FOR ALPHA-SYNUCLEIN-RELATED DISORDERS | BIOARCTIC AB (SE) | 2018-11-21 | — | — | EP | claimed |
| EP-3171171-B1 | RECOMBINANT DEAMIDATED GLIADIN ANTIGEN | BIO RAD LABORATORIES (US) | 2018-07-18 | — | — | EP | claimed |
| EP-3010534-B1 | PHARMACEUTICAL FORMULATIONS AND METHODS FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE INGREDIENT | TRANSGENE BIOTEK TLD (IN) | 2018-05-30 | — | — | EP | claimed |
| EP-2494075-B1 | TEMPLATED NANOCONJUGATES | UNIV NORTHWESTERN (US) | 2018-04-04 | — | — | EP | claimed |
| US-9663814-B2 | Proximity assay for in situ detection of targets | VENTANA MEDICAL SYSTEMS, INC. (US) | 2017-05-30 | — | — | US | claimed |
| EP-2788760-B1 | RECOMBINANT DEAMIDATED GLIADIN ANTIGEN | BIO RAD LABORATORIES INC (US) | 2017-02-15 | — | — | EP | claimed |
| EP-1853634-B1 | ACTIVATED SIALIC ACID DERIVATIVES FOR PROTEIN DERIVATISATION AND CONJUGATION | LIPOXEN TECHNOLOGIES LTD (GB) | 2016-08-10 | — | — | EP | claimed |
| EP-1776389-B1 | SIALIC ACID DERIVATIVES | LIPOXEN TECHNOLOGIES LTD (GB) | 2016-06-29 | — | — | EP | claimed |
| EP-2971064-A1 | PROXIMITY ASSAY FOR IN SITU DETECTION OF TARGETS | Ventana Medical Systems, Inc. (US) | 2016-01-20 | — | — | EP | claimed |
| WO-2014139980-A1 | PROXIMITY ASSAY FOR IN SITU DETECTION OF TARGETS | VENTANA MEDICAL SYSTEMS, INC. (US) | 2014-09-18 | — | — | WO | claimed |
| EP-2132332-B1 | MEASUREMENT OF AN INSOLUBLE ANALYTE IN A SAMPLE | HIGH THROUGHPUT GENOMICS INC (US) | 2014-01-22 | — | — | EP | claimed |
| EP-2276499-B1 | RECOMBINANT DEAMIDATED GLIADIN ANTIGEN | BIO RAD LABORATORIES (US) | 2013-06-12 | — | — | EP | claimed |
| EP-2126584-B1 | DIRECT MASS SPECTROMETRIC ANALYSIS OF DRUG CANDIDATES TARGETING PROTEIN COMPLEXES | COVALX AG (CH) | 2012-12-19 | — | — | EP | claimed |
| EP-2095129-B1 | DIRECT MASS SPECTROMETRIC ANALYSIS OF SELF-AGGREGATES OF THERAPEUTIC PROTEINS | COVALX AG (SE) | 2011-02-23 | — | — | EP | claimed |
| EP-0701448-B1 | AMPLIFICATION OF THE VITAMIN B 12 UPTAKE SYSTEM USING POLYMERS | BIOTECH AUSTRALIA PTY LTD (AU) | 2002-08-14 | — | — | EP | claimed |
| US-5427929-A | Enzyme pretreatment | AMGEN INC. (US) | 1995-06-27 | — | — | US | claimed |
| EP-0220030-B1 | ORAL DELIVERY SYSTEM | BIOTECHNOLOGY AUSTRALIA PTY. LTD. (AU) | 1991-06-19 | — | — | EP | claimed |
| WO-1988008875-A1 | CYCLING BIOCHIP SENSOR | THE WASHINGTON TECHNOLOGY CENTER (US) | 1988-11-17 | — | — | WO | claimed |
| EP-0184710-A2 | Magnetic microspheres | BAYER AG (DE) | 1986-06-18 | — | — | EP | claimed |